Pulmonx Corporation (Nasdaq: LUNG) ('Pulmonx” or the 'Company'), a global leader in minimally invasive treatments for lung ...

Newswatch 16's Justin Gick spoke with a pulmonologist about the signs and symptoms of COPD and when to see a doctor.

Pulmonx is positioned at the bottom for Revenue Growth, with a negative growth rate. It is also at the bottom for Gross ...

Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsGlendon French - CEO, President & DirectorDerrick ...

Pulmonx Corporation ( ($LUNG) ) has released its Q3 earnings. Here is a breakdown of the information Pulmonx Corporation presented to its ...

COPD is a group of lung diseases that get worse over time. It prevents airflow to the lungs, causing breathing problems and ...

Both indoor and outdoor air quality impact chronic obstructive pulmonary disease (COPD), which opens up a large avenue to work with patients to improve their outcomes. For COPD patients, the adage ...

Please provide your email address to receive an email when new articles are posted on . In those with and those without a history of CVD/metabolic disease, patients receiving dupilumab vs. placebo had ...

Altis Zephyr is a 2yo b unknown from Japan trained by Kazuma Yabuguchi, who is based at . It is sired by the stallion Pas De Trois out of the dam Sakura Coffretd'or. Altis Zephyr is yet to break its ...

Glen French, member of the Board of Directors and former Pulmonx President and Chief Executive Officer, reappointed President and Chief Executive OfficerDerrick Sung, former Pulmonx Chief Financial Of ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.